Literature DB >> 8624248

Immunolocalization of interleukin-4 in eosinophils in the bronchial mucosa of atopic asthmatics.

G M Möller1, T A de Jong, T H van der Kwast, S E Overbeek, A F Wierenga-Wolf, T Thepen, H C Hoogsteden.   

Abstract

Several studies have shown that human eosinophils can synthesize and release a number of cytokines. The aim of this study was to investigate whether eosinophils contain interleukin (IL)-4 protein. We examined the ultrastructural localization of IL-4 in eosinophils in bronchial mucosal biopsies of 29 nonsmoking atopic asthmatics and 7 controls. No eosinophils were detected in the bronchial mucosa of controls. In the eosinophils (n = 42) of the asthmatics, IL-4 was localized to the electron-dense crystalloid core compartment of 85% of the secondary or specific eosinophil granules (n = 468). Other structures in the eosinophils were unlabeled. Control sections, incubated with an irrelevant primary antibody, were negative. This study demonstrates that pre-formed IL-4 is stored in the secondary eosinophil granules. These results were extended by light microscopic immunodouble-staining for IL-4 protein and eosinophil cationic protein, which showed that a subpopulation of activated eosinophils express IL-4 immunoreactivity in bronchial mucosal biopsies of asthmatics as well as controls. These data indicate that eosinophils may be an important source of IL-4 in allergic inflammation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8624248     DOI: 10.1165/ajrcmb.14.5.8624248

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  18 in total

Review 1.  Mechanisms of eosinophil cytokine release.

Authors:  Christianne Bandeira-Melo; Peter F Weller
Journal:  Mem Inst Oswaldo Cruz       Date:  2005-06-14       Impact factor: 2.743

2.  A gel-based dual antibody capture and detection method for assaying of extracellular cytokine secretion: EliCell.

Authors:  Lisa A Spencer; Rossana C N Melo; Sandra A C Perez; Peter F Weller
Journal:  Methods Mol Biol       Date:  2005

Review 3.  Contributions of electron microscopy to understand secretion of immune mediators by human eosinophils.

Authors:  Rossana C N Melo; Ann M Dvorak; Peter F Weller
Journal:  Microsc Microanal       Date:  2010-09-27       Impact factor: 4.127

Review 4.  Mechanisms of eosinophil secretion: large vesiculotubular carriers mediate transport and release of granule-derived cytokines and other proteins.

Authors:  Rossana C N Melo; Lisa A Spencer; Ann M Dvorak; Peter F Weller
Journal:  J Leukoc Biol       Date:  2007-09-17       Impact factor: 4.962

5.  Cytokine production from sputum cells in eosinophilic versus non-eosinophilic asthmatics.

Authors:  V Quaedvlieg; M Henket; J Sele; R Louis
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

6.  Effects of low-dose-gamma rays on the immune system of different animal models of disease.

Authors:  Noriko Shimura; Shuji Kojima
Journal:  Dose Response       Date:  2014-04-23       Impact factor: 2.658

7.  Intragranular vesiculotubular compartments are involved in piecemeal degranulation by activated human eosinophils.

Authors:  Rossana C N Melo; Sandra A C Perez; Lisa A Spencer; Ann M Dvorak; Peter F Weller
Journal:  Traffic       Date:  2005-10       Impact factor: 6.215

8.  Human eosinophils secrete preformed, granule-stored interleukin-4 through distinct vesicular compartments.

Authors:  Rossana C N Melo; Lisa A Spencer; Sandra A C Perez; Ionita Ghiran; Ann M Dvorak; Peter F Weller
Journal:  Traffic       Date:  2005-11       Impact factor: 6.215

Review 9.  T cell co-stimulatory molecules: a co-conspirator in the pathogenesis of eosinophilic esophagitis?

Authors:  Zili Zhang; Thomas J Sferra; Yasemen Eroglu
Journal:  Dig Dis Sci       Date:  2013-03-02       Impact factor: 3.199

10.  Cytokine receptor-mediated trafficking of preformed IL-4 in eosinophils identifies an innate immune mechanism of cytokine secretion.

Authors:  Lisa A Spencer; Rossana C N Melo; Sandra A C Perez; Staci P Bafford; Ann M Dvorak; Peter F Weller
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.